Cargando…

Cutaneous adverse drug reactions induced by Oxcarbazepine

Detalles Bibliográficos
Autores principales:	Hsiao, Yi-Hsin, Chung, Wen-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127561/ http://dx.doi.org/10.1186/2045-7022-4-S3-O12

Ejemplares similares

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

Overlap between maculopapular exanthema and DRESS among cutaneous adverse drug reactions in a dermatology ward (2008-2012)
por: Gouveia, Miguel Pinto, et al.
Publicado: (2014)

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions
por: Ko, Tai-Ming, et al.
Publicado: (2014)

Oxcarbazepine-induced tardive dyskinesia: A rare adverse reaction
por: Hergüner, M. Özlem, et al.
Publicado: (2010)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
por: Tiwattanon, Kanyawan, et al.
Publicado: (2022)

Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital
por: Lee, Jung Eun, et al.
Publicado: (2020)

Spectrum of adverse cutaneous eruptions to nevirapine – a cross sectional study
por: Budamakuntla, Leelavathy, et al.
Publicado: (2012)

Oxcarbazepine-induced systemic lupus erythematosus: A rare and serious adverse drug reaction to a common anticonvulsant
por: Sinha, Anwita, et al.
Publicado: (2021)

Highlights of the 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, London, November 2010
por: Schambelan, M
Publicado: (2010)

Malignant hyperthermia testing in probands with NO adverse anesthetic reaction
por: Sterling, Carly, et al.
Publicado: (2014)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014)

Profilin desensitisation in patients with adverse reaction after plant-derived: our experience
por: Mezzacappa, Simona, et al.
Publicado: (2015)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

An immunohistochemical study of the granulysin expression of 6 types of proven adverse cutaneous drug reaction
por: Weinborn, Marie, et al.
Publicado: (2014)

Uncontrolled headache induced by oxcarbazepine
por: Piovesan, Elcio Juliato, et al.
Publicado: (2007)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
por: Hu, H, et al.
Publicado: (2012)

Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022)

Drug-specific in vitro release of IFN-gamma in patients with delayed cutaneuos drug hypersensitivity reactions
por: Porebski, Grzegorz, et al.
Publicado: (2015)

Drugs inducing T-cell mediated cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells
por: Gonçalo, Margarida, et al.
Publicado: (2014)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
por: Romoli, Michele, et al.
Publicado: (2015)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Muco-cutaneous manifestations in HIV infection/AIDS
por: Benea, Vasile, et al.
Publicado: (2014)

HLA Association with Drug-Induced Adverse Reactions
por: Fan, Wen-Lang, et al.
Publicado: (2017)

Differential cytokine/chemokine profiles and reactivation of human herpes viruses in various forms of cutaneous adverse drug reactions. A comparative study in Taiwan
por: Chu, Chia-Yu, et al.
Publicado: (2014)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

S6.4c Primary cutaneous implantation coccidioidomycosis
por: Bonifaz, Alexandro, et al.
Publicado: (2022)

P094 Atypical cutaneous manifestations of sporotrichosis in Brazil
por: Batista, Camila, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jbcsto0tka9rcbo41hv1is38p1